1. Home
  2. OI vs VCEL Comparison

OI vs VCEL Comparison

Compare OI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo O-I Glass Inc.

OI

O-I Glass Inc.

HOLD

Current Price

$15.40

Market Cap

2.3B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.36

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OI
VCEL
Founded
1903
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
OI
VCEL
Price
$15.40
$37.36
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$17.43
$57.50
AVG Volume (30 Days)
2.3M
586.8K
Earning Date
02-10-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$6,455,000,000.00
$258,716,999.00
Revenue This Year
$1.41
$17.86
Revenue Next Year
$1.99
$18.55
P/E Ratio
N/A
$151.65
Revenue Growth
N/A
14.05
52 Week Low
$9.23
$29.24
52 Week High
$16.04
$63.00

Technical Indicators

Market Signals
Indicator
OI
VCEL
Relative Strength Index (RSI) 55.84 48.73
Support Level $14.95 $35.99
Resistance Level $16.03 $41.65
Average True Range (ATR) 0.45 1.75
MACD -0.02 -0.01
Stochastic Oscillator 52.24 32.12

Price Performance

Historical Comparison
OI
VCEL

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: